Sunrest Lifescience

Sunrest Lifescience EPS Growth

The EPS Growth of Sunrest Lifescience (SUNREST.NS) as of Nov 3, 2026 is 587.22 %. In the previous year, EPS Growth was -85.71 % — a change of -785.09% (higher).

EPS Growth

587.22 %

YoY

-785.09%

Last updated:

EPS Growth of Sunrest Lifescience is 2025 587.22 % . EPS Growth of Sunrest Lifescience was 2024 -85.71 % . It decreases by -785.09% higher compared to the previous year.

The Sunrest Lifescience EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2022
364.10 INR
Jan 1, 2023
162.98 INR
Jan 1, 2024
-85.71 INR
Jan 1, 2025
587.22 INR
The Sunrest Lifescience EPS Growth history
YEAREPS GrowthYoY
587.22 %-785.09%
-85.71 %-152.59%
162.98 %-55.24%
364.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sunrest Lifescience Stock analysis

What does Sunrest Lifescience do? Sunrest Lifescience Ltd markets OTC generic pharmaceutical products manufactured by third party manufacturers. The company sells capsules, tablets, syrup, ointment, gel, mouth wash, solution, suspension, dry powders, and toothpaste. Its product portfolio includes Anti-Bacterial, Anti Diarrheal, Antifungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory drugs. The company operates in Maharashtra, Gujarat, Madhya Pradesh, Orissa, and Rajasthan, selling to stockists who distribute products to chemist shops, dispensaries, and hospitals. Sunrest Lifescience Ltd targets domestic markets through third party manufacturers for OTC generic products. The firm's sales channels include stockists who supply chemist shops, dispensaries, and hospitals across multiple Indian states. The company's product range serves various health segments from anti-bacterial treatments to multivitamins and dental care. The company's revenue comes from the sale of OTC generic pharmaceutical products to stockists, who then distribute them to end consumers via chemist shops, dispensaries, and hospitals. Sunrest Lifescience Ltd focuses on domestic market distribution without direct retail presence, leveraging third party manufacturers for product supply. Sunrest Lifescience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunrest Lifescience stock

EPS Growth of Sunrest Lifescience is 587.22 % in 2025.

On Eulerpool you can find the complete historical development of EPS Growth Sunrest Lifescience since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's Sunrest Lifescience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Sunrest Lifescience

All Key Metrics — Sunrest Lifescience